b-Catenin is constantly degraded through the ubiquitinproteasomal pathway. In this study, we report that a different type of b-catenin degradation is causally involved in epidermal cell death. We observed that reactive oxygen species (ROS) caused b-catenin degradation in the epidermal cells through a caspase-dependent mechanism, which results in disruption of cell adhesion. Disruption of cell adhesion increased ROS and activated caspases. Upregulation of the intact b-catenin blocked ROS accumulation and caspase activation. These results indicate that a feed-forward loop consisting of ROS, caspases activation and b-catenin degradation induces epidermal cell death.
Introduction
b-Catenin is a component of cell adherens junction (AJ) and also functions as a transcription factor involved in cell proliferation and differentiation (Clevers, 2006; Perez-Moreno and Fuchs, 2006) . At steady state, cytosolic b-catenin is rapidly degraded by a destruction complex involving adenomatous polyposis coli (APC), axin, glycogen synthase kinase 3b (GSK3b) and casein kinase (Brembeck et al., 2006; Clevers, 2006; Xu and Kimelman, 2007) . b-Catenin is phosphorylated by GSK3b, which targets it for proteasome degradation. b-Catenin is an abundantly produced protein; however, through this homeostatic b-catenin degradation pathway, the level of b-catenin is kept constant. It has been reported that b-catenin can be cleaved by protease including caspases and calpains (Brancolini et al., 1997 (Brancolini et al., , 1998 Van de Craen et al., 1998 Steinhusen et al., 2000; Li and Iyengar, 2002; Abe and Takeichi, 2007) .
In neuronal cells, the calpain-dependent cleavage stabilizes and stimulates transcriptional activity of b-catenin (Abe and Takeichi, 2007) . In other cell types, b-catenin cleavage has been reported as one of the consequences of apoptosis (Brancolini et al., 1997; Bannerman et al., 1998; Brancolini et al., 1998) .
Transforming growth factor b-activated kinase 1 (TAK1) is a member of mitogen-activated protein kinase kinase kinase, and is an indispensable signaling intermediate in mitogen-activated protein kinase-activator protein-1 and nuclear factor-kB pathways (Ninomiya-Tsuji et al., 1999; Takaesu et al., 2001; Shim et al., 2005) . Activator protein-1 and nuclear factor-kB are major transcriptional factors of cellular anti-oxidant genes such as ferritin and glutamylcysteine ligase (Go et al., 2004; Pham et al., 2004; Yang et al., 2005) . Ablation of TAK1 impairs mitogen-activated protein kinase and nuclear factor-kB pathways resulting in reduced cellular antioxidant capacity . We have previously reported that tak1-deficient cells are hypersensitive to reactive oxygen species (ROS inducers), because ROS are accumulated much higher levels in tak1-deficient cells compared with wild-type cells . In epidermal cells (keratinocytes), we have previously found that tumor necrosis factor (TNF) is a strong inducer of ROS in tak1-deficient conditions . In tak1-deficient epidermis of the skin, keratinocytes undergo TNF-ROS-induced apoptosis . However, the underlying mechanism through which ROS kill keratinocytes has not been fully defined. In the present study, we investigate how ROS cause keratinocyte apoptosis both in cultured cells and in an in vivo setting by using TNFinduced ROS in tak1-deficient cells as model systems. We observed that ROS-induced apoptosis is accompanied by caspase-dependent degradation of b-catenin. Furthermore, we found that this non-canonical b-catenin degradation is not only the result of caspase activation but is also the cause of apoptosis.
Results

ROS cause b-catenin degradation in the in vivo epidermis
We analyzed two mouse models as follows: one having an inducible epidermal-specific deletion of tak1 (K14-CreERT tak1 flox/flox ) and the other having a constitutive epidermal-specific deletion of tak1 (K5-Cre tak1 flox/flox ) mice ( Figure 1 ). TNF is always expressed at some levels in the normal skin, which is important for basal immunity (Pasparakis et al., 1996; Pasparakis et al., 1997) . In the tak1-deficient epidermis, this TNF sufficiently induces ROS-dependent cell death . We treated 5-weeks-old K14-CreERT tak1 flox/flox mice with 4-hydroxy tamoxifen (Figure 1a ), which induced tak1 gene deletion and increased apoptotic epidermal cells as previously reported . We found that b-catenin was greatly decreased in the epidermis of 4-hydroxy tamoxifen-treated K14-CreERT tak1 flox/flox mice (Figure 1a ). The amount of intact b-catenin was diminished and several smaller degraded forms of b-catenin were observed. The degradation of b-catenin was blocked by feeding the mice a diet containing anti-oxidant butylated hydroxyanisole (BHA), suggesting that the degradation of b-catenin is associated with increased ROS (Figure 1a ). Neonatal mice with constitutive epidermal-specific Figure 1c ). Impaired membrane localization of b-catenin was observed in the most areas of P4 TAK1 mutant skin, whereas b-catenin was largely diminished in some areas of P5 in TAK1 mutant skin.
ROS induce b-catenin degradation and disruption of cell adhesion
To further analyze the degradation of b-catenin, we utilized cultured tak1-deficient (D/D) keratinocytes Figure 2 (a) The tak1 wild-type ( þ / þ ) and tak1-deficient (D/D) keratinocytes were stimulated with 20 ng/ml TNF for 3 or 6 h, and b-catenin was detected by immunoblot. (b) Cells with TNF stimulation were subsequently incubated with 10 mM CM-H2DCFDA for 30 min, and cells were analyzed by flow cytometry. The fluorescence units relative to that of unstimulated cells are shown. (c) tak1 D/D keratinocytes were pretreated with 100 mM BHA or vehicle ethanol for 1 h and stimulated with 20 ng/ml TNF for 3 or 6 h. b-catenin was detected by immunoblot. (d) tak1 þ / þ and D/D keratinocytes were pretreated with 100 mM BHA or vehicle ethanol for 1 h and stimulated with 20 ng/ml TNF for 6 h. Cell viability was measured by MTT assay. Data are the mean ± s.e. of three samples. (e) tak1 D/D keratinocytes were cultured in calcium-containing media for 2 h and subsequently stimulated with 20 ng/ml TNF for 24 h. Immunostainig of b-catenin (red), cleaved caspase 3 (green) and phalloidin (green) are shown. The 46-diamidino-2-phenyl indole staining is shown in blue. Scale bar, 20 mm. The cells having diffuse b-catenin, punctate phalloidin and cleaved caspase 3 staining were counted in three independent samples. Cleaved caspase 3-positive percentage of total diffuse b-catenin cells, 97.9 ± 1.3% (mean ± s.d.). Cleaved caspase 3-positive percentage of total punctate phalloidin cells, 100%.
b-Catenin degradation mediates cell death E Omori et al (Omori et al., 2006) . We have previously reported that TNF induces accumulation of ROS and caspase activation leading to apoptotic cell death in tak1-deficient keratinocytes, whereas no wild-type keratinocyte undergoes apoptosis upon TNF stimulation . We found that the level of b-catenin was diminished in TNF-stimulated tak1-deficient (D/D) but not in tak1 wild-type ( þ / þ ) keratinocytes (Figure 2a ), and restoration of wild-type tak1 (D/D þ TAK1) blocked the b-catenin degradation (Supplementary Figure S1A ). Decreased b-catenin in TNF-stimulated tak1-deficient keratinocytes was correlated with the accumulation of ROS and cell death (Figures 2b and d) . The reduction of b-catenin and cell death was abolished by pretreatment of BHA (Figures 2c and d) , which is consistent with the in vivo results in mouse epidermis ( Figure 1a ). We observed cells having diffuse non-membranebound staining of b-catenin in TNF-treated tak1deficient (D/D) (Figure 2e , asterisks). In all, 98% of diffuse b-catenin cells were co-stained with cleaved caspase 3, indicating that they were apoptotic. Furthermore, phalloidin staining displayed a punctate pattern and retraction of fibers, indicating that disruption of actin filament and cell adhesions (AJs) were associated with the loss of membrane-bound b-catenin (Figure 2e , arrows). All the cells showing the disruption of actin filament were co-stained with cleaved caspase 3. These results suggest that b-catenin degradation is associated with the disruption of AJs. We also observed decreased amounts of other AJ components, E-cadherin and p120 catenin in TNF-stimulated tak1-deficient keratinocytes, and the reduction of those proteins was blocked by the anti-oxidant BHA treatment (Supplementary Figure  S1B) . These results suggest that AJs were disrupted via ROS in TNF-treated tak1-deficient keratinocytes.
Caspases degrade b-catenin
We next examined whether the reduction of b-catenin is mediated through the GSK3b-mediated proteasomal degradation pathway. We pretreated tak1-deficient keratinocytes with several types of inhibitors including proteasomal inhibitors (MG132 and lactacystin) and a GSK3b inhibitor (LiCl), and then stimulated the cells with TNF. Degradation of b-catenin was inhibited by pretreatment of a proteasomal inhibitor, MG132 or lactacystin ( Figure 3 ), but inhibition of GSK3b had almost no effect on TNF-induced b-catenin degradation. We found that a caspase inhibitor, Z-VAD-fmk (Z-VAD) abolished degradation of b-catenin and a calpain inhibitor N-acetyl-Leu-Leu-methional less effectively inhibited degradation of b-catenin (Figure 3 and Supplementary Figure S1C ). Therefore, it is likely that TNF-induced ROS do not degrade b-catenin through the homeostatic GSK3b pathway, but it may be through a non-canonical pathway, which involves caspases.
b-Catenin degradation is causally involved in apoptosis
Epidermis is characterized by tightly connected cells (Perez-Moreno and Fuchs, 2006). AJs are important for maintenance of this tight connection, and disruption of cell-cell connection is known to be associated with apoptosis (Steinhusen et al., 2000; Perez-Moreno and Fuchs, 2006) . Therefore, we postulated that b-catenin degradation-associated AJ disruption might not only be the result of caspase activation but also be causally involved in apoptosis in keratinocytes. To test this hypothesis, we attempted to prevent the reduction of the level of b-catenin, and examined TNF-induced apoptosis. We stably introduced a vector expressing b-catenin into tak1-deficient keratinocytes by using the retrovirus system. However, we noted that the level of b-catenin was not noticeably increased by the b-catenin vector infection in unstimulated keratinocytes. We postulated that b-catenin degradation through the GSK3b-proteasomal pathway might mask the increased b-catenin expression. To verify this, we used S33Y-b-catenin, which is not phosphorylated by GSK3b or degraded through the canonical pathway (Supplementary Figure  S2) . The expression level of S33Y-b-catenin was higher than that in the wild-type b-catenin or control vectorinfected unstimulated keratinocytes (Supplementary Figure S2B) , which is consistent with our hypothesis. We found that the stable introduction of even the wildtype b-catenin vector could maintain intact b-catenin at nearly control levels following TNF stimulation (Figure 4b and Supplementary Figure S2B ). Exogenous expression of either wild-type or S33Y-b-catenin reduced the number of TNF-induced morphologically apoptotic (shrink) cells and annexin V-binding positive cells (Figure 4a and Supplementary Figure S2A ). Activation of caspase 3 was found to be blocked by b-catenin overexpression (Figure 4b ). Furthermore, b-catenin overexpression could effectively block ROS accumulation (Figure 4c ).
We showed above that a proteasomal inhibitor MG132 reduced b-catenin degradation (Figure 3) . Therefore, we also examined whether MG132-mediated upregulation of b-catenin could modulate caspase, ROS and cell survival (Supplementary Figure S3 ). MG132 completely abolished TNF-induced caspase-3 activation and ROS accumulation. Collectively, maintenance of intact b-catenin level can block caspase 3 activation and ROS accumulation. These results indicate These results led us to hypothesize that ROS, caspase activation and b-catenin degradation form a feed-forward loop lead to keratinocyte apoptosis (see Figure 7 ). If our hypothesis is correct, disrupting any of them should block all other events. Indeed, we showed above that reduction of ROS by the antioxidant BHA blocked caspase activation and b-catenin degradation (Figures 1 and 2) , and that inhibition of caspases blocked b-catenin degradation (Figure 3) . We next examined whether inhibition of caspases could block ROS accumulation. We treated tak1-deficient keratinocytes with Z-VAD and determined the levels of TNF-induced ROS (Figure 5a ). Inhibition of caspases completely abolished the accumulation of ROS (Figure 5a ) and reduced the number of shrinking cells and annexin V-binding positive cells (Figure 5b ) in tak1-deficient keratinocytes, following TNF stimulation. These results are consistent with our killing loop hypothesis.
The ROS-caspase-b-catenin degradation loop kills epidermal cells
If there is such a feed-forward loop shown in Figure 7 , any of the events, including ROS accumulation, caspase activation and b-catenin degradation, should be capable of initiating the loop leading to keratinocyte death. We attempted to trigger the ROS-caspase-b-catenin degradation loop by stimuli other than the TNF-induced ROS. We mimicked b-catenin-induced AJ disruption by trypsin treatment of cells. Trypsin-treated keratinocytes exhibited b-catenin degradation (Figure 6a ). Concomitantly, ROS was highly increased (Figure 6b) , caspase 3 was activated (Figure 6a ) and cells died (Figure 6c) .
These results indicate that disruption of cell adhesion can initiate the ROS-caspase-b-catenin degradationkilling loop. Staurosporine, a non-specific kinase inhibitor, impairs mitochondrial function and is commonly used as an inducer of apoptosis (Tafani et al., 2001; Tafani et al., 2002) . We treated wild-type keratinocytes with staurosporine and observed that it induced b-catenin degradation, caspase activation, ROS accumulation and cell death (Figures 6d-f ). Staurosporine-induced b-catenin degradation and caspase activation were blocked by BHA treatment (Supplementary Figure S4) . Thus, staurosporin can activate the ROS-caspase-b-catenin degradation loop. To determine whether this loop mediates cell killing in other epithelial cells, we analyzed human embryonic kidney 293 cells stimulated with combination of TNF-related apoptosis-inducing ligand and cycloheximide, which is an inducer of apoptosis in 293 cells. We detected cleavage of b-catenins, and observed a moderate increase of caspases 3 activation and ROS accumulation (Figures 6g-i) .
Discussion
Collectively, these results support the idea that there is a ROS-caspase-b-catenin degradation loop, which functions to kill epithelial cells (Figure 7) . ROS are known to damage mitochondria and promote caspase activation (Lin and Beal, 2006) . When ROS are accumulated and damage mitochondria or when cell adhesion is disrupted, the feed-forward loop consisting of ROS, caspases and b-catenin degradation, is activated and irreversibly kills the damaged epidermal cells. This killing loop is likely to be important for securely eliminating damaged epithelial cells, promoting repair and preventing potential carcinogenesis in the epidermis.
Materials and methods
Mice tak1-floxed (tak1 flox/flox ) mice were from Dr Akira, Osaka University (Sato et al., 2005) . Mice harboring an epidermalspecific constitutive tak1 deletion (K5-Cre tak1 flox/flox ) were generated using K5-Cre mice (mixed background of C57LBL/6 Figure 5 (a) The tak1 þ / þ and D/D keratinocytes were pretreated with or without 20 mM Z-VAD-fmk or dimethyl sulfoxide for 1 h, and stimulated with 20 ng/ml TNF for 2 or 4 h. Cells were subsequently incubated with 10 mM CM-H 2 DCFDA for 30 min and analyzed by flow cytometry. The fluorescence units relative to that of unstimulated cells are also shown. (b) tak1 D/D keratinocytes were pretreated with 20 mM Z-VAD-fmk or dimethyl sulfoxide for 1 h and stimulated with 20 ng/ml TNF for 4 h, and apoptotic cells were stained by Annexin V-Alexa Fluor 488.
b-Catenin degradation mediates cell death E Omori et al and DBA/2J). K14-CreERT mice were obtained from the Jackson Labs (Bar Harbor, ME, USA) (Vasioukhin et al., 1999) . Mice harboring an epidermal-specific inducible tak1 deletion (K14-CreERT tak1 flox/flox ) were generated, and at 5 weeks of age were topically treated on the dorsal skin once a day for 5 consecutive days with 4-hydroxy tamoxifen (1 mg per mouse) b-Catenin degradation mediates cell death E Omori et al . Some mice were fed with food containing 0.7% BHA, starting at 3 days before the tamoxifen treatment. tak1 gene deletion was examined by PCR described previously. Littermate controls were used in all experiments. All animal experiments were done with the approval of the North Carolina State University Institutional Animal Care and Use Committee.
Cell culture tak1 þ / þ and tak1 D/D keratinocytes were isolated from tak1 flox/flox , K5-Cre tak1 flox/flox mice, described previously (Omori et al., 2006) . Spontaneously immortalized keratinocytes derived from the skin of postnatal day 0-2 mice were cultured in Ca 2 þ -free minimal essential medium (Lonza, Basel, Switzerland) supplemented with 4% chelex-treated bovine growth serum (Hyclone, Logan, UT, USA), 10 ng/ml of human or murine epidermal growth factor (Peprotech, Rocky Hill, NJ, USA), 0.05 mM calcium chloride and penicillin-streptomycin at 33 1C in 8% CO 2 .
Reagents
Reagents used were TNF-a (Peprotech), BHA, lithium chloride, 4-hydroxy tamoxifen (Sigma, St Louis, MO, USA), MG132, Z-VAD-fmk, Staurosporine, N-acetyl-Leu-Leu-methional (Calbiochem, Gibbstown, NJ, USA), clasto-lactacystin b-lactone (Cayman, Ann Arbor, MI, USA), TNF-related apoptosis-inducing ligand (Peprotech) and cycloheximide (Merck, Darmstadt, Germany). Polyclonal anti-bodies were caspase 3 and cleaved caspase 3 (Cell Signaling, Danvers, MA, USA). Monoclonal anti-bodies were b-catenin, p120-catenin (BD, Franklin Lakes, NJ, USA), b-actin (Sigma) and E-cadherin (ZYMED, San Francisco, CA, USA). Alexa Fluor 488 phalloidin (Invitrogen, Carlsbad, CA, USA) was used.
Immunoblotting
Keratinocytes were washed once with ice-cold phosphatebuffered saline and whole cell extracts were prepared using a lysis buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4), 150 mM NaCl, 12.5 mM b-glycerophosphate, 1.5 mM MgCl 2 , 2 mM ethylene glycol tetraacetic acid, 10 mM NaF, 2 mM dithiothreitol, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 20 mM aprotinin and 0.5% Triton X-100). Cell extracts were resolved on SDS-polyacrylamide gel electrophoresis and transferred to Hybond-P membranes (GE Healthcare, Piscataway, NJ, USA). The membranes were immunoblotted with various anti-bodies, and the bound anti-bodies were visualized with horseradish peroxidase-conjugated anti-bodies against rabbit or mouse immunoglobulin G using the ECL or ECL advance Western blotting detection kit (GE Healthcare).
Immunohistochemistry
Bouin-fixed paraffin sections were heated in 10 mM citrate buffer for 10 min, and b-catenin immunofluorescence staining was performed. The dUTP nick-end labeling (TUNEL) assay was performed on Bouin-fixed paraffin sections using an apoptotic cell death detection kit (Promega, Madison, WI, USA), according to the manufacturer's instructions. Sections were counterstained with 46-diamidino-2-phenylindole.
Cell viability assay
To determine the number of viable cells, a modified version of 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay, MTS assay, was performed according to the manufacturer's instructions (Promega).
Retroviral infection
Retroviral vectors for TAK1 (pMX-puro-TAK1) weres described previously (Kim et al., 2008) . b-catenins (pMXpuro-b-catenin WT and S33Y) were generated by inserting bcatenin complimentary DNA into the retroviral vector, which was generated from pMX-puro (Kitamura, 1998) . b-catenin complimentary DNAs (Kolligs et al., 1999) were gifts from Dr Eric R Fearon, The University of Michigan Health System. EcoPack293 cells (BD) were transiently transfected with the various b-catenin vectors. After 48 h culture, growth medium containing retrovirus was collected and filtered with 0.45 mm cellulose acetate membrane to remove packaging cells. Keratinocytes were incubated with the collected virus-containing medium with 8 mg/ml polybrene for 24 h. Uninfected cells were removed by puromycin selection.
ROS measurement
Cells were stimulated, and then incubated with 10 mM CM-H 2 DCFDA (Invitrogen) for 30 min at 37 1C. Harvested cells were analyzed by flow cytometry and FlowJo software (Tree Star Inc., Ashland, OR, USA). One representative data from 2-3 similar results were shown in each experiment.
Trypsin treatment
Keratinocytes were trypsinized and incubated in Ca 2 þ -free minimal essential medium, with no calcium on plates coated with poly-2-hydroxyethyl methacrylate (10 mg/ml, Sigma).
Annexin V-binding assay
To determine apoptotic cells, Annexin V-Alexa Fluor 488 binding was performed according to the manufacturer's protocol (Invitrogen), and fluorescence was detected with fluorescent microscope (Olympus, Center Valley, PA, USA). In all, 5-6 randomly selected areas were photographed with the same exposure time. The images were processed using the same fixed threshold in all samples by Photoshop software (Adobe, San Jose, CA, USA), and representative images are shown. The annexin positive cells were counted in total at least Figure 6 (a-c) The tak1 þ / þ keratinocytes were trypsinized and cultured in calcium free media for 3 or 15 h. Cell lysates were immunoblotted with anti-b-catenin and anti-caspase 3 (a). Cells were incubated with 10 mM CM-H 2 DCFDA for 30 min and analyzed by flow cytometry (b). The fluorescence units relative to that of unstimulated cells are also shown (a, bottom). Cell viability was measured by MTT assay. Data are the mean ± s.e. of three samples (c). (d-f) tak1 þ / þ keratinocytes were stimulated with 0.5 mM staurosporine (STS; Calbiochem) for 3 or 5.5 h. Cells were analyzed as described above. (g-i) HEK293 cells were prestimulated with 100 mg/ml cycloheximide for 1 h, and stimulated with 100 ng/ml TNF-related apoptosis-inducing ligand (TR) for 2 or 6.5 h. Cells were analyzed as described above.
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